联环药业(600513.SH)：第三季度净利润496.62万元，同比下降83.34%

Core Viewpoint - Lianhuan Pharmaceutical (600513.SH) reported a significant increase in revenue for the third quarter, but a substantial decline in net profit, indicating potential challenges in profitability despite revenue growth [1] Financial Performance - The company achieved a revenue of 797 million yuan in the third quarter, representing a year-on-year increase of 53.81% [1] - The net profit attributable to shareholders was 4.9662 million yuan, showing a year-on-year decrease of 83.34% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 278.83 thousand yuan, reflecting a year-on-year decline of 90.50% [1] - Basic earnings per share were reported at 0.02 yuan [1]